Article: Operational barriers to the implementation of multidrug therapy and leprosy elimination in Cameroon

Introduction

In 1980, the drug of choice for leprosy treatment was dapsone but because of widespread resistance, treatment became increasingly ineffective. Also, treatment was life-long, which discouraged the patients. [1]

Multidrug therapy (MDT) is a combination of three drugs for multibacillary leprosy and two drugs for paucibacillary cases. [1],[2] MDT enjoys a high degree of patient acceptability, with very low relapse rates following completion of treatment. Compliance is high because of the fixed and relatively short duration of treatment, low frequencies of side-effects, cost-effectiveness and definitive cure in the patient. [3],[4],[5],[6] Despite all these advantages, challenges ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!